ÂÜÀòÂÒÂ×

Jung Eun Jang is an experienced scientist specializing in immunology and oncology, currently employed at Adaptive Biotechnologies Corp. as a Scientist since October 2020, focusing on TCR discovery and characterization. Prior to this role, Jung Eun Jang worked at Genentech as a Senior Scientific Researcher from August 2017 to March 2020, where responsibilities included executing in vitro assays for mRNA cancer vaccines and conducting pharmacodynamic efficacy studies. Jung Eun Jang's background also includes a position as a Postdoctoral Fellow at New York University School of Medicine from February 2012 to July 2017, researching immune cell dynamics in pancreatic cancer models, and a tenure as a Graduate Research Assistant at the Icahn School of Medicine at Mount Sinai from September 2006 to January 2012, studying neutrophil roles in sickle cell disease. Jung Eun Jang earned a Doctor of Philosophy (Ph.D.) in Immunology from the Icahn School of Medicine at Mount Sinai in 2012.